Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a glucagon-like peptide-1 receptor agonist, reduces appetite and slows stomach emptying to support sustained weight loss. PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan from licensed 503A compounding pharmacies, making this evidence-based therapy accessible nationwide without insurance or hidden fees.
Start a Semaglutide program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded Semaglutide, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.
Start your intake →
Understanding Compounded Semaglutide vs. Brand-Name Versions
Brand-name semaglutide (Ozempic, Wegovy) and compounded semaglutide contain the same active pharmaceutical ingredient but differ in sourcing and cost. Compounded semaglutide is manufactured by licensed 503A compounding pharmacies under strict pharmaceutical regulations, ensuring consistent strength and purity without the premium pricing of brand-name versions. The compounding process allows personalized dosing flexibility and eliminates supply chain constraints that often limit brand-name availability.
Clinical studies show that compounded GLP-1 medications deliver equivalent metabolic outcomes when dosed appropriately and monitored by a qualified healthcare provider. The cost advantage of compounded options—PlexusDx charges a flat monthly rate regardless of dose level—makes long-term weight loss therapy sustainable for patients without insurance coverage. This accessibility has expanded GLP-1 therapy to millions of individuals who previously faced financial or logistical barriers.
How to Purchase Compounded Semaglutide Safely and Legally
Purchasing compounded semaglutide requires a valid prescription from a licensed physician or healthcare provider with prescribing authority in your state. PlexusDx connects qualified patients with prescribers through a straightforward telehealth consultation process; no in-person visit is required for most states. Once approved, your prescription is filled by a licensed 503A compounding pharmacy and shipped directly to your home, with delivery typically occurring within 5–7 business days.
All compounded medications through PlexusDx originate from licensed 503A compounding pharmacies—never 503B facilities—ensuring compliance with FDA oversight and state pharmacy regulations. Your compounded semaglutide vials include sterile needles, detailed injection instructions, and dosing guidance aligned with clinical protocols. PlexusDx maintains full transparency about the compounding pharmacy and ingredient sourcing, and customers receive documentation suitable for HSA/FSA reimbursement if applicable.
Pricing, Dosing, and Cost Transparency for Compounded Semaglutide
PlexusDx offers compounded semaglutide injections at a flat monthly rate of $189 per month across three commitment tiers, with prices ranging $189/mo month-to-month, or from $149/mo on the 6-month plan depending on your subscription level. The pricing structure reflects PlexusDx's core principle: your dose may need to go up, but your price won't. This means you can begin at a lower starting dose and increase gradually as your body adapts without facing escalating monthly costs, removing a major barrier to safe, evidence-based dose titration.
No insurance is required, no membership fees apply, and HSA and FSA accounts are eligible for reimbursement. The transparent, all-inclusive pricing allows patients to budget predictably for their weight loss journey. Compared to brand-name semaglutide copays that often exceed $200–$300 monthly, compounded semaglutide through PlexusDx represents a significant cost reduction without compromising quality or clinical outcomes.
The Role of Genetic Testing in Personalizing Your Semaglutide Therapy
PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway genetic assessment that identifies how your body may respond to GLP-1 medications based on key genetic variants including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. By mapping 14 metabolic pathways, 49 peptides, and 150+ genetic insights, this test reveals your unique predisposition to weight loss response, side effect tolerance, and optimal medication choice. Adding genetic testing after your first month of treatment is $298 and provides actionable data to refine your therapy.
Patients with specific genetic profiles may respond more effectively to semaglutide alone, while others benefit from dual-compound approaches like GLP-Squared (semaglutide plus tirzepatide). This personalization reduces trial-and-error prescribing and accelerates the path to sustainable weight loss. Your PlexusDx provider uses genetic insights alongside your clinical history to recommend the most effective protocol, improving both outcomes and treatment satisfaction.
Safety, Side Effects, and Medical Monitoring With Compounded Semaglutide
Common side effects of semaglutide include nausea, vomiting, diarrhea, and constipation, typically most pronounced during initial dose escalation and often improving within 1–2 weeks as your body adjusts. Serious but rare adverse events include pancreatitis, gallbladder disease, and thyroid concerns; semaglutide is contraindicated in individuals with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. PlexusDx requires a comprehensive health screening during your telehealth consultation to identify contraindications before prescribing.
Ongoing medical supervision is essential for safe semaglutide use. PlexusDx provides regular check-ins with your healthcare provider to monitor weight loss progress, assess tolerability, adjust dosing, and screen for adverse effects. Monthly or quarterly follow-up appointments allow your prescriber to ensure your compounded semaglutide remains appropriate and effective, with the flexibility to switch to alternative GLP-1 compounds if needed. This continuity of care distinguishes supervised compounded therapy from unmonitored online purchases.
Comparing Compounded Semaglutide Injection to Oral and Dual-Compound Options
Compounded semaglutide injection ($189/mo) remains the most cost-effective and bioavailable option, with rapid onset and predictable pharmacokinetics. Oral semaglutide ($289/mo) offers convenience for patients who prefer pills but requires specific administration protocols (fasting, 30 minutes before food) and has lower absorption rates. Patients seeking stronger efficacy may prefer GLP-Squared Injection—a dual-compound combining semaglutide and tirzepatide—starting at $289/mo, or GLP-Squared Oral at $389/mo (or $369/mo on the 3-month plan) for those prioritizing pill form.
Your prescriber will recommend the optimal formulation based on your metabolic profile, lifestyle, genetic predispositions (if tested), and weight loss goals. Injectable formulations generally deliver faster and more reliable results, while oral options appeal to needle-averse patients. PlexusDx also offers the Microdose GLP-1 Protocol at $129/mo for those starting at the lowest-dose threshold or seeking a trial period before committing to full-strength therapy.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide as safe and effective as brand-name Ozempic or Wegovy?
Yes, compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient and delivers equivalent clinical outcomes when prescribed and monitored appropriately by a healthcare provider. The main differences are cost, personalized dosing flexibility, and availability; efficacy and safety profiles are comparable when used under medical supervision.
Do I need insurance to buy compounded semaglutide from PlexusDx?
No, PlexusDx requires no insurance, no membership fees, and no hidden charges. Compounded semaglutide is $189 per month month-to-month, or from $149/mo on the 6-month plan and is available to all 50 states. If you have HSA or FSA coverage, compounded semaglutide is eligible for reimbursement.
How long does it take to receive compounded semaglutide after I get a prescription?
After your telehealth consultation and prescription approval, your compounded semaglutide is filled by a licensed 503A compounding pharmacy and shipped to your home within 5–7 business days. Most patients receive their first shipment within 1–2 weeks of starting the enrollment process.
What happens if I experience side effects from compounded semaglutide?
PlexusDx provides ongoing medical supervision and regular check-ins with your prescriber to monitor tolerability and adjust dosing as needed. Common side effects like nausea typically resolve within 1–2 weeks; if side effects persist or worsen, your provider may slow dose escalation, switch to oral semaglutide, or recommend an alternative GLP-1 compound like tirzepatide.
How can the Precision Peptide Genetic Test help me choose between semaglutide and other GLP-1 options?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss: Can You Take Phentermine and Tirzepatide Together?
Understanding Non-GLP-1 Medications: A Comprehensive Exploration